News | August 13, 2023
Aurobindo Pharma reports Q1 FY24 consolidated PAT at Rs. 570.75 Cr
Aurobindo Pharma has reported total income of Rs. 6966.85 crores during the period ended June 30, 2023
Aurobindo Pharma has reported total income of Rs. 6966.85 crores during the period ended June 30, 2023
Krsnaa Diagnostics has reported total income of Rs. 143.80 crores during the period ended June 30, 2023
Panacea Biotec has reported total income of Rs. 135.27 crores during the period ended June 30, 2023
Gujarat Themis Biosyn has reported total income of Rs. 50.66 crores during the period ended June 30, 2023
IPCA Laboratories has reported total income of Rs. 1632.43 crores during the period ended June 30, 2023
India is committed to eliminating Lymphatic Filariasis by 2027, three years ahead of the global target through mission mode, multi partner, multi sector targeted drive
The medical device sector is considered as one of the sunrise sectors in the country
The company has reported total income of Rs. 75.26 crores during the period ended June 30, 2023
Hester Biosciences has reported total income of Rs. 88.99 crores during the period ended June 30, 2023
Suven Life Sciences has reported total income of Rs. 9.43 crores during the period ended June 30, 2023
Subscribe To Our Newsletter & Stay Updated
